Authors:
BROOKS DP
ADAMS J
DEPALMA PD
WEBB EF
GRISWOLD DE
PALMER R
Citation: Dp. Brooks et al., THE SELECTIVE CYCLOOXYGENASE-2 (COX-2) INHIBITOR, CELECOXIB, BUT NOT 6MNA, AFFECTS RENAL HEMODYNAMIC AND RENAL-FUNCTION IN THE DOG, Journal of investigative medicine, 46(3), 1998, pp. 227-227
Authors:
LAPING NJ
OLSON BA
DAY JR
BRICKSON BM
CONTINO LC
SHORT BG
ALI SM
BROOKS DP
Citation: Nj. Laping et al., THE AGE-RELATED INCREASE IN RENAL CLUSTERIN MESSENGER-RNA IS ACCELERATED IN OBESE ZUCKER RATS, Journal of the American Society of Nephrology, 9(1), 1998, pp. 38-45
Authors:
PARAMESWARAN N
SPIELMAN WS
PULLEN M
FRANCIS J
BROOKS DP
NAMBI P
Citation: N. Parameswaran et al., ADRENOMEDULLIN INCREASES HYALURONIC-ACID PRODUCTION IN RAT GLOMERULARMESANGIAL CELLS, The FASEB journal, 12(4), 1998, pp. 893-893
Authors:
RASMUSSEN TE
JOUGASAKI M
SUPAPORN T
HALLETT JW
BROOKS DP
BURNETT JR
Citation: Te. Rasmussen et al., CARDIOVASCULAR ACTIONS OF ET-B ACTIVATION IN-VIVO AND MODULATION BY RECEPTOR ANTAGONISM, American journal of physiology. Regulatory, integrative and comparative physiology, 43(1), 1998, pp. 131-138
Authors:
OLSON BA
ALI SM
CONTINO LC
BROOKS DP
LAPING NJ
Citation: Ba. Olson et al., ANGIOTENSIN-CONVERTING ENZYME-INHIBITION ALTERS CLUSTERIN MESSENGER-RNA EXPRESSION IN THE KIDNEY FOLLOWING RENAL MASS REDUCTION, Pharmacology, 57(1), 1998, pp. 13-19
Authors:
ALI SM
LAPING NJ
FREDRICKSON TA
CONTINO LC
OLSON BA
ANDERSON K
BROOKS DP
Citation: Sm. Ali et al., ANGIOTENSIN-CONVERTING ENZYME-INHIBITION ATTENUATES PROTEINURIA AND RENAL TGF-BETA-1 MESSENGER-RNA EXPRESSION IN RATS WITH CHRONIC RENAL-DISEASE, Pharmacology, 57(1), 1998, pp. 20-27
Citation: Dp. Brooks et Lc. Contino, INVOLVEMENT OF NITRIC-OXIDE SYNTHASE IN PROTEINURIA ASSOCIATED WITH CHRONIC RENAL-DISEASE IN RATS, Pharmacology, 56(5), 1998, pp. 257-261
Authors:
GELLAI M
SCHREINER GF
RUFFOLO RR
FLETCHER T
DEWOLF R
BROOKS DP
Citation: M. Gellai et al., CVT-124, A NOVEL ADENOSINE A(1) RECEPTOR ANTAGONIST WITH UNIQUE DIURETIC ACTIVITY, The Journal of pharmacology and experimental therapeutics, 286(3), 1998, pp. 1191-1196
Authors:
OHLSTEIN EH
NAMBI P
HAY DWP
GELLAI M
BROOKS DP
LUENGO J
XIANG JN
ELLIOTT JD
Citation: Eh. Ohlstein et al., NONPEPTIDE ENDOTHELIN RECEPTOR ANTAGONISTS - XI - PHARMACOLOGICAL CHARACTERIZATION OF SB-234551, A HIGH-AFFINITY AND SELECTIVE NONPEPTIDE ETA-RECEPTOR ANTAGONIST, The Journal of pharmacology and experimental therapeutics, 286(2), 1998, pp. 650-656
Authors:
BARONE FC
COATNEY RW
NELSON AH
CAMPBELL WG
SARKAR SK
OHLSTEIN EH
CHANDRA S
BROOKS DP
FEUERSTEIN GZ
Citation: Fc. Barone et al., CARVEDILOL ELIMINATES MORTALITY AND CARDIORENAL HISTOPATHOLOGY, IMPROVES CARDIAC-FUNCTION ASCERTAINED BY ULTRASOUND AND MRI AND IMPROVES RENAL-FUNCTION IN SEVERE HYPERTENSION-INDUCED HEART AND RENAL-FAILURE, Circulation, 98(17), 1998, pp. 2915-2915
Authors:
BROOKS DP
DEPALMA PD
PULLEN M
ELLIOTT J
OHLSTEIN E
NAMBI P
Citation: Dp. Brooks et al., THE NOVEL ETA RECEPTOR ANTAGONIST, SB-234551, UNMASKS ENDOTHELIN-MEDIATED VASODILATION AND ATTENUATES RADIO-CONTRAST-INDUCED NEPHROPATHY INDOGS, Journal of the American Society of Nephrology, 8, 1997, pp. 2795-2795
Authors:
ALI SM
NAMBI P
FREDRICKSON TA
KIKLY K
BROOKS DP
Citation: Sm. Ali et al., APOPTOSIS AND EPITHELIN MESSENGER-RNA EXPRESSION IN THE POLYCYSTIC (CPK) MOUSE KIDNEY, The FASEB journal, 11(3), 1997, pp. 2122-2122
Citation: Eh. Ohlstein et al., INHIBITION OF SYMPATHETIC OUTFLOW BY THE ANGIOTENSIN-II RECEPTOR ANTAGONIST, EPROSARTAN, BUT NOT BY LOSARTAN VALSARTAN OR IRBESARTAN - RELATIONSHIP TO DIFFERENCES IN PREJUNCTIONAL ANGIOTENSIN-II RECEPTOR BLOCKADE, Pharmacology, 55(5), 1997, pp. 244-251
Authors:
NAMBI P
PULLEN M
KINCAID J
NUTHULAGANTI P
AIYAR N
BROOKS DP
GELLAI M
KUMAR C
Citation: P. Nambi et al., IDENTIFICATION AND CHARACTERIZATION OF A NOVEL ENDOTHELIN RECEPTOR THAT BINDS BOTH ETA-SELECTIVE AND ETB-SELECTIVE LIGANDS, Molecular pharmacology, 52(4), 1997, pp. 582-589
Authors:
BROOKS DP
ALI SM
CONTINO LC
STACK E
FREDRICKSON TA
FEILD J
EDWARDS RM
Citation: Dp. Brooks et al., PHOSPHATE EXCRETION AND PHOSPHATE TRANSPORTER MESSENGER-RNA IN UREMICRATS TREATED WITH PHOSPHONOFORMIC ACID, The Journal of pharmacology and experimental therapeutics, 281(3), 1997, pp. 1440-1445
Authors:
BROOKS DP
VALENTE M
PETRONE G
DEPALMA PD
SBACCHI M
CLARKE GD
Citation: Dp. Brooks et al., COMPARISON OF THE WATER DIURETIC ACTIVITY OF KAPPA-RECEPTOR AGONISTS AND A VASOPRESSIN RECEPTOR ANTAGONIST IN DOGS, The Journal of pharmacology and experimental therapeutics, 280(3), 1997, pp. 1176-1183
Authors:
RASMUSSEN TE
JOUGASAKI M
SUPAPORN T
HALLETT JW
BROOKS DP
BURNETT JC
Citation: Te. Rasmussen et al., CARDIOVASCULAR ACTIONS OF ENDOTHELIN-B RECEPTOR ACTIVATION IN-VIVO INTHE PRESENCE AND ABSENCE OF ENDOTHELIN-B RECEPTOR INHIBITION, Journal of investigative medicine, 44(7), 1996, pp. 385-385
Authors:
ALI SM
FREDRICKSON TA
PULLEN M
WU HL
CONTINO LC
NAMBI P
BROOKS DP
Citation: Sm. Ali et al., SELECTIVE ACTIVATION OF PROTEIN-KINASE C-BETA-2 IN CYCLOSPORINE-A-INDUCED NEPHROTOXICITY, Journal of the American Society of Nephrology, 7(9), 1996, pp. 2953-2953
Authors:
BROOKS DP
ALI SM
CONTINO LC
STACK E
FREDRICKSON TA
FEILD J
EDWARDS RM
Citation: Dp. Brooks et al., PHOSPHATE EXCRETION AND PHOSPHATE TRANSPORTER MESSENGER-RNA EXPRESSION IN UREMIC RATS TREATED WITH PHOSPHONOFORMIC ACID, Journal of the American Society of Nephrology, 7(9), 1996, pp. 3022-3022
Authors:
ALI SM
FREDERICKSON TA
PULLEN M
BROOKS DP
GELLAI M
NAMBI P
Citation: Sm. Ali et al., REGULATION OF RENAL ENDOTHELIN RECEPTOR SUBTYPES DURING THE DEVELOPMENTAL PHASE OF HYPERTENSION IN THE RAT, The FASEB journal, 10(3), 1996, pp. 4039-4039
Authors:
WANG YX
CROFTON JT
MILLER J
SIGMAN CJ
LIU HW
HUBER JM
BROOKS DP
SHARE L
Citation: Yx. Wang et al., SEX DIFFERENCE IN URINARY CONCENTRATING ABILITY OF RATS WITH WATER-DEPRIVATION, American journal of physiology. Regulatory, integrative and comparative physiology, 39(3), 1996, pp. 550-555
Citation: Dp. Brooks, SYMPOSIUM ON ENDOTHELIN RECEPTORS - ROLE IN RENAL-FUNCTION AND DYSFUNCTION, Clinical and experimental pharmacology and physiology, 23(4), 1996, pp. 325-325
Citation: Dp. Brooks, ROLE OF ENDOTHELIN IN RENAL-FUNCTION AND DYSFUNCTION, Clinical and experimental pharmacology and physiology, 23(4), 1996, pp. 345-348